Because TP53 is frequently mutated in liver cancer, we investigated the relationship between TP53 mutations and SOD2 expression in the survival of HCC patients using genomic and clinical data from cBioPortal for Cancer Genomics (http://www.cbioportal.org). Here, SOD2 is linked to hepatocellular carcinoma.